Biosafety and biosecurity for pathogens and toxins news: Q3, February 2024 issue

On this page

Report on the Human Pathogens and Toxins Regulations consultation

The Centre for Biosecurity (CB) recently completed a thematic consultation to help shape potential changes to the Human Pathogens and Toxins Regulations (HPTR). We were pleased to receive responses from a broad range of partners and stakeholders, including individuals and organizations. They provided insight from a number of perspectives, including:

In keeping with the Government of Canada's commitment to greater transparency and accountability, we published a ‘What we heard' report. This report summarizes the feedback and outlines how this information will be used to shape the development of HPTR amendments. The report is now available on the What we heard: Consultation on potential amendments to the Human Pathogens and Toxins Regulations web page.

Canadian Biosafety App version 3.0

The Canadian Biosafety Standard (CBS), Third Edition came into effect on April 1, 2023. The Canadian Biosafety App version 3.0 is now available in both online and mobile versions. It's a practical tool that makes it easier to see the CBS requirements for your facility, based on specific activities and regulated materials.

The online version lets you:

In addition to the features described above, the mobile version provides the full text of the CBS, a link to the Public Health Agency of Canada (PHAC) Training Portal, and links to content such as biosafety guidelines, directives and advisories. Most features in the mobile app can also be used offline. It's a free download for both Android and Apple devices.

We will update the app as new content becomes available.

Contact us at pathogens.pathogenes@phac-aspc.gc.ca if you have any questions.

Laboratory Incident Notification Canada's 2022 annual report

Laboratory Incident Notification Canada (LINC) published its 2022 annual report in September 2023. It describes laboratory exposure incidents in Canada and those affected by these incidents.

Online learning opportunities

On September 27, 2023, the Centre for Biosecurity (CB) held a 60-minute webinar titled “Laboratory Incidents: How, when and what to report”. The goals of the webinar were to summarize and clarify best practices for reporting laboratory incidents, and to answer participants' questions. In this webinar presented by LINC, speakers outlined the mandatory and voluntary reporting process for laboratory incidents under the Human Pathogens and Toxins Act (HPTA) and Human Pathogens and Toxins Regulations (HPTR).

On November 23, 2023, CB held the ‘What's new in the Centre for Biosecurity' webinar. The aim of the presentation was to raise awareness and share information about the most common types of exposure incidents in Canada.

Some highlights included:

On January 25, 2024, CB held a webinar on Biocontainment considerations: design, operation and commissioning. The purpose of this webinar was to discuss topics related to biocontainment design and operational considerations, including:

Presenters also discussed the laboratory commissioning process and how it adds to the overall building commissioning.

You can access webinar recordings through the Public Health Agency of Canada's Training Portal.

Upcoming webinars

New printable tools

CB has developed new resources to support laboratories with their reporting obligations for exposure incidents involving human pathogens and toxins. These are in addition to the existing printable laboratory biosafety signage and information sheets.

The new resources include:

You must still submit incident reporting forms using the Biosecurity Portal.

You can access these printable tools through the PHAC Training Portal.

RegFacts: #DYK: Your legal obligations to notify 

If you conduct controlled activities under the HPTA or HPTR, you have a legal obligation to notify CB when certain situations occur in your facility.

The following resources can help you understand situations that require notification:

Remember to include the applicable requirements for notification in your emergency response plan.

Types of controlled activities conducted under your licence

The biological safety officer (BSO) is responsible for overseeing biosafety and biosecurity practices related to a Pathogen and Toxin Licence (PTL). As the primary contact, the BSO communicates with CB on behalf of the licence holder.

The BSO must be fully aware of all controlled activities involving human pathogens or toxins that take place in their organization, including:

Unless exempted or excluded, you must not conduct a controlled activity without a licence issued by the Minister to authorize that activity. The BSO must ensure that every activity is authorized under the organization's PTL.

If your organization wishes to conduct an activity that isn't listed on the PTL, the BSO must submit a request for a licence variation through the Biosecurity Portal. To report an activity not authorized by the PTL, the BSO must submit a notification report through the Biosecurity Portal.

Contact the licensing team at licence.permis@phac-aspc.gc.ca if you have any questions.

Responsibilities of the HPTA security clearance holder

You need a valid security clearance issued under the HPTA to access without escort any part of a facility where security sensitive biological agents (SSBAs) are used to conduct controlled activities. These areas are called SSBA zones. Before issuing a security clearance, PHAC verifies that the person won't pose a security risk if they are granted unescorted access to a SSBA zone. The licence holder is responsible for ensuring that HPTA security clearance holders can fulfill their obligations.

As a HPTA security clearance holder, you:

Other obligations as a HPTA security clearance holder include:

As a HPTA security clearance holder, you also have responsibilities related to sensitive information. You must:

As a HPTA security clearance holder, you must also comply with any other obligations developed by your facility.

For more information about your responsibilities and obligations, please consult:

For questions about applying for a HPTA security clearance:

New condition of licence: Keep contact information up to date

The PTL's new format came into effect on June 26, 2023. It's now organized by location rather than by authorized activities. As such, authorized biological agents, animal species and controlled activities are listed directly under each approved facility location in a single table.

A new condition of licence was introduced to require that the licence holder keep contact details of individuals associated with the licence up to date at all times. This information must also be provided to PHAC. This requirement existed in a previous CBS edition (4.1.3, CBS2), but was removed from the third edition, and is now a standard condition for all licences. Individuals associated with the licence include the:

If you have any questions on how to update your contact details, please contact licence.permis@phac-aspc.gc.ca.

Protecting facilities: Personnel and visitors

All licensed organizations in Canada must develop a comprehensive biosecurity plan, in accordance with the CBS. This biosecurity plan must be based on a biosecurity risk assessment. The assessment is designed to protect and secure assets, including:

People are vital to your facility's success, safety, and security. The licence holder is responsible for establishing measures to protect the health and well-being of personnel and anyone visiting their facilities. This responsibility includes putting measures in place to ensure the success of the biosafety and biosecurity measures in place.

Comprehensive screening and background checks for all people in the facility helps prevent security violations. They help assess the risk that someone in the facility may be targeted or the facility's biosafety and biosecurity may be compromised or threatened by bad actors. Organizations should implement strong visitor policies and procedures related to personnel security in their biosecurity plans, including:

In addition, organizations should consider:

For more information, please refer to:

If you have questions about preparing for visitors or conducting a risk assessment, please contact biosafety.biosecurite@phac-aspc.gc.ca.

Risk groups: What they are and why they matter

Biological agents are classified into 1 of 4 risk groups (RG) based on factors such as:

Biological agents can be:

Biological agents classified as RG1 are considered to present the lowest risk whereas those classified as RG4 are considered to present the highest risk to individuals and communities.

Type of risk RG 1 RG 2 RG 3 RG 4
Individual Low Moderate High High
Community Low Low Low High

The RG classification of a biological material generally dictates the laboratory containment level (CL) required for handling it (for example RG2 pathogens are handled at CL2), with some exceptions.

Unless excluded or exempt, facilities that conduct controlled activities with RG2, RG3 and RG4 human or animal pathogens or toxins require 1 or both of:

Well-characterized biological materials with a pathogen risk assessment completed by PHAC or the CFIA have been assigned a RG and CL. The RG classification of thousands of biological agents is available in the online ePATHogen database. It provides a comprehensive and up-to-date list of biological agents and their RG classifications, CL requirements and other regulatory information.

Most of the RG classifications listed in the ePATHogen database are shown at the species level, or they may refer to a particular:

RG classifications are also shown at the genus-level. However, unless a lack of information requires your pathogen to be classified at the genus level, best practices for determining the RG of a pathogen are to classify it at the strain or isolate level. For example Escherichia spp. are classified as RG2 for humans and animals at the genus-level (see table). However, certain species within the genus are classified as RG1 for humans and animals (for example, E. blattae). Others are classified as RG2 for humans and animals (for example, E. coli). Similarly, E. coli is classified as RG2 for humans and animals at the species-level. However, certain strains or isolates are classified as RG1 for humans and animals (for example, strain K12).

Genus Genus RG Species Species RG Isolate / Strain Isolate / Strain RG
Escherichia spp. RG2 E. blattae RG1 - -
Escherichia spp. RG2 E. coli RG2 E. coli K12 RG1

To find out the RG classification for a biological agent not listed in the ePATHogen database, complete a pathogen risk assessment using the template below.

Submit the completed risk assessment to PHAC at pathogens.pathogenes@phac-aspc.gc.ca for validation.

Regulation of cells and cell lines under the HPTA and HPTR

Some cells or cell lines may also be regulated under HPTA and HPTR. Cell lines with a PHAC-completed risk assessment are listed in the ePATHogen database. A Statement of Administrative Intent clarifies the circumstances under which cells or cell lines are controlled under the HPTA. Generally, they don't meet the definition of a pathogen. However, if they contain or produce an intact RG2, RG3, or RG4 human pathogen or toxin, they're controlled under the HPTA.

If it's unclear to a facility whether the cell or cell line contains an intact RG2, RG3, or RG4 human pathogen or toxin, then a risk assessment should be conducted. It should consider whether the cell or cell line:

Always consult PHAC about the RG classification and CL requirements for cells and cell lines.

Don't use RG or biosafety level classification published by other organizations

RG or biosafety level (BSL) classifications published by other organizations (for example, culture collections, distributors, manufacturers, and other countries) have no regulatory significance under the HPTA and HPTR. They may, but don't always, align with Canadian RG classifications and CL requirements. Always consult the ePATHogen database to determine the RG and CL of your biological agent or cell line.

If in doubt, ask us

If you have any questions about risk assessments or RG classifications, including biological agents or cell lines not listed in the ePATHogen database, contact us at pathogens.pathogenes@phac-aspc.gc.ca.

Page details

Date modified: